<DOC>
	<DOCNO>NCT01418846</DOCNO>
	<brief_summary>The purpose study investigate intra-saliva penetration voriconazole different subpopulation . The goal develop , optimize validate easy , non-invasive painless procedure Therapeutic Drud Monitoring voriconazole use child , ambulatory patient patient blood draw difficult .</brief_summary>
	<brief_title>Determination Voriconazole Levels Saliva - Validation Specific Subsets Patients</brief_title>
	<detailed_description />
	<mesh_term>Voriconazole</mesh_term>
	<criteria>patient adult hematology ward treat voriconazole pediatric patient treated voriconazole , age 518 year patient pneumology ward treat voriconazole Age 5 year Women pregnant lactate Mucositis stage 3 4 ( WHO ) Patients receive follow drug within 14 day study entry : rifampicin , rifabutin , carbamazepine , phenytoin , phenobarbital , nevirapine , efavirenz barbiturate . Patients receive follow drug within 24hours study entry : quinidine , ergotamine , sirolimus , saquinavir , amprenavir , nelfinavir , ritonavir sulphonylureas .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>voriconazole</keyword>
	<keyword>saliva</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>